Menu Close

Human Immunodeficiency Virus in Transgender Persons

Citation

Ackerley, Cassie G.; Poteat, Tonia; & Kelley, Colleen F. (2019). Human Immunodeficiency Virus in Transgender Persons. Endocrinology and Metabolism Clinics of North America, 48(2), 453-64.

Abstract

Worldwide, transgender populations are disproportionately affected by human immunodeficiency virus (HIV). Pervasive stigma and discrimination impact social and economic determinants of health, which perpetuate HIV disparities among transgender individuals. This article reviews the prevalence of HIV infection among transgender populations and presents psychosocial, behavioral, and individual level factors that contribute to HIV acquisition. The authors provide practical recommendations regarding a patient-centered approach to HIV/sexually transmitted infection risk assessment. The role of preexposure prophylaxis utilization in preventing the transmission of HIV is discussed as well as the current data on HIV treatment outcomes for transgender people living with HIV.

URL

http://dx.doi.org/10.1016/j.ecl.2019.02.007

Reference Type

Journal Article

Journal Title

Endocrinology and Metabolism Clinics of North America

Author(s)

Ackerley, Cassie G.
Poteat, Tonia
Kelley, Colleen F.

Year Published

2019

Volume Number

48

Issue Number

2

Pages

453-64

Reference ID

12863